ReviewTranslational oncology2026
CCL2: A double-edged sword in neuroblastoma, with a critical role in MYCN-amplified tumors.
Léo Jannot et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ReviewTranslational oncology2026
Léo Jannot et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.